Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akamai

78.19
-0.0800-0.10%
Post-market: 78.11-0.0800-0.10%18:55 EDT
Volume:3.62M
Turnover:284.21M
Market Cap:11.43B
PE:26.32
High:79.66
Open:78.50
Low:77.94
Close:78.27
Loading ...

Street Calls of the Week

Investing.com
·
23 Feb

Weekly Roundup: US Stocks Slide as STI Posts Modest Gains and HSI Rally For The Sixth Straight Week

The Smart Investor
·
23 Feb

Why Akamai Technologies, Inc. (AKAM) Crashed on Friday

Insider Monkey
·
23 Feb

Craig-Hallum downgrades Akamai to Hold following ‘disappointing’ guide

TipRanks
·
22 Feb

Akamai Technologies, Inc. (NASDAQ:AKAM) Just Reported, And Analysts Assigned A US$107 Price Target

Simply Wall St.
·
22 Feb

Akamai Technologies’ Earnings Call Highlights Growth and Challenges

TIPRANKS
·
22 Feb

Post-Bell|S&P 500, Nasdaq End Down Nearly 2%; UnitedHealth Declines 7%; Coinbase Sinks 8%; Block Falls 18%; Celsius Holdings Soars 28%

Tiger Newspress
·
22 Feb

Economic Data Drag Equity Markets Lower

MT Newswires
·
22 Feb

Akamai Technologies Inc. Stock Sheds 21.7%, Underperforms Competitors

Dow Jones
·
22 Feb

US STOCKS-Wall Street ends sharply lower on mounting concerns over economy, tariffs

Reuters
·
22 Feb

Why Akamai (AKAM) Stock Is Trading Lower Today

StockStory
·
22 Feb

US STOCKS-Wall Street slides on mounting concerns over economy, tariffs

Reuters
·
22 Feb

Akamai Stock Heads for Biggest Loss in 8 Years -- Barrons.com

Dow Jones
·
22 Feb

Top Midday Decliners

MT Newswires Live
·
22 Feb

US Equity Indexes Drop as Worsening Consumer Sentiment, Output Growth Pushes Treasury Yields Lower

MT Newswires Live
·
22 Feb

Akamai Shares Fall After 'Muted' Guidance

MT Newswires Live
·
22 Feb

US Equity Indexes Decline Amid Worsening Consumer Sentiment, Output Growth

MT Newswires Live
·
22 Feb

Akamai's Transformation: Cybersecurity and Cloud Growth Amid CDN Challenges

GuruFocus
·
22 Feb

BUZZ-Akamai Technologies tumbles after weak 2025 revenue forecast

Reuters
·
22 Feb

BUZZ-U.S. STOCKS ON THE MOVE-MercadoLibre, CrowdStrike Holdings, Protagonist Therapeutics

Reuters
·
22 Feb